The resistome and other mechanisms of antibiotic resistance

Georgina Cox (Hamilton, Canada)

Source: International Congress 2015 – Antibiotic resistance in respiratory infections
Session: Antibiotic resistance in respiratory infections
Session type: Hot topics
Number: 3442
Disease area: Respiratory infections

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Georgina Cox (Hamilton, Canada). The resistome and other mechanisms of antibiotic resistance. International Congress 2015 – Antibiotic resistance in respiratory infections

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Antibiotic resistance in pulmonary infections: mechanisms and epidemiology
Source: Eur Respir Monogr 2017; 75: 21-43
Year: 2017


Impact of antibiotic consumption in the evolution of respiratory pseudomonas antibiotic resistance
Source: Eur Respir J 2006; 28: Suppl. 50, 787s
Year: 2006

Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance
Source: Eur Respir J, 49 (6) 1700223; 10.1183/13993003.00223-2017
Year: 2017



When and how to identify resistance mechanisms to targeted therapies
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Year: 2019


The role of increasing bacterial resistance
Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections
Year: 2012

Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB
Source: Eur Respir J 2009; 33: 581-585
Year: 2009



Antibiotic management and resistance
Source: Eur Respir Monogr 2018; 81: 312-330
Year: 2018


Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis.
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Macrolide resistance in Pseudomonas aeruginosa: implications for practice
Source: Eur Respir J, 49 (5) 1700689; 10.1183/13993003.00689-2017
Year: 2017



Mechanisms of acquisition of resistance in Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen?
Year: 2006


Epidemiological impact of antibiotic use/misuse in the community
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=165
Year: 2004

MDR pathogens: definitions, mechanisms and risk factors
Source: International Congress 2015 – PG14 Antibiotic stewardship for respiratory infections
Year: 2015



Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Year: 2020

Biological resistance to beta-lactamic antibiotics in patients with respiratory infection in the prediction of efficiency of antibacterial therapy
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020

Fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis independent of fluoroquinolone use
Source: Eur Respir J, 50 (6) 1701633; 10.1183/13993003.01633-2017
Year: 2017



Rapid molecular detection of rifampicin and isoniazid resistance and identification of mutations in resistant genes of multi-drug resistant tuberculosis (MDR-TB) patients
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011